Cryosite Limited

Cryosite was established with the specific objective of providing specialised clinical trials depot services to a wide range of clients from the research, medical, pharmaceutical and biotechnology industries.

In the highly regulated, complicated, clinical trial environment, our mission is simple: we take care of your warehousing, distribution and logistics needs so you can concentrate on your core objectives.

Gain a direct line to Cryosite leadership

Be first to know our latest company updates

Watch exclusive videos accompanying major news

Why invest

Meet the team

News & Media

Announcements

Home

What We Do

My Shareholding

Investor Relations FAQ

Shareholder Information

Questrial

Cryosite Investor Hub

CTE Cryosite RaaS Watchlist Report 2025 10 07.pdf

Cryosite is pleased to share a commissioned research report, published by Naheed Rahman from RaaS Advisory, which recognises our leadership in temperature-controlled storage and logistics for the life sciences and pharmaceutical industries. 

The report highlights strong growth in our Ultra-Frozen and Cryogenic business, robust financial performance, and expansion plans into a newly acquired freehold warehouse that position Cryosite to capture increasing demand across Australia and the Asia-Pacific region.

The full report is attached to this update.

If you would like to discuss the report, our business, or visit either of our sites, please feel free to reach out directly to me on the details below.

Cryosite Featured in RaaS Advisory Research Report